Simulation training as a response to the demand of critical patients COVID19: safety and quality of care

Detalhes bibliográficos
Autor(a) principal: Souza, Luís Manuel Mota de
Data de Publicação: 2020
Outros Autores: Marques, Maria do Céu Mendes Pinto
Tipo de documento: Artigo
Idioma: por
eng
Título da fonte: Revista Ciências em Saúde
Texto Completo: https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1009
Resumo: Coronavirus Disease (COVID-19), also known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first described in December 2019 in Wuhan, China. It has spread across all continents and was declared by the World Health Organization (WHO), on March 11, 2020, as a global pandemic. On June 24, 2020, 9,129,146 cases and 473,797 deaths from SARS-CoV-2 / COVID 19 were reported by the WHO. The virus is transmitted through droplets, although it has also been found in feces and blood, thus allowing other means of potential transmission. The symptoms associated with SARS-CoV -2 infection include fever, myalgia or fatigue, productive cough or non-productive cough dyspnoea, fatigue, or myalgia in most cases. There are also reports of symptoms such as headache, sore throat, hemoptysis and gastrointestinal symptoms such as diarrhea, nausea and abdominal pain, but with less incidence.  
id RCS_c4e0cd420315def4aad27d6fe47f630f
oai_identifier_str oai:ojs.portalrcs.hcitajuba.org.br:article/1009
network_acronym_str RCS
network_name_str Revista Ciências em Saúde
repository_id_str
spelling Simulation training as a response to the demand of critical patients COVID19: safety and quality of careTreinamento por simulação como resposta à demanda dos pacientes críticos COVID19: segurança e qualidade na assistênciaCOVID-19pandemicCOVID-19pandemiaCoronavirus Disease (COVID-19), also known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first described in December 2019 in Wuhan, China. It has spread across all continents and was declared by the World Health Organization (WHO), on March 11, 2020, as a global pandemic. On June 24, 2020, 9,129,146 cases and 473,797 deaths from SARS-CoV-2 / COVID 19 were reported by the WHO. The virus is transmitted through droplets, although it has also been found in feces and blood, thus allowing other means of potential transmission. The symptoms associated with SARS-CoV -2 infection include fever, myalgia or fatigue, productive cough or non-productive cough dyspnoea, fatigue, or myalgia in most cases. There are also reports of symptoms such as headache, sore throat, hemoptysis and gastrointestinal symptoms such as diarrhea, nausea and abdominal pain, but with less incidence.  A Coronavirus Disease (COVID-19), também denominada por severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), foi descrita pela primeira vez no mês de dezembro de 2019, em Wuhan, na China. Esta disseminou-se por todos os continentes, tendo sido declarada pela Organização Mundial da Saúde (OMS), em 11 de março de 2020, como uma pandemia global. No dia 24de junho de 2020, estavam reportados pela OMS 9.129.146 casos e 473.797 mortes causadas pelo SARS-CoV-2/COVID 19. A transmissão do vírus é feita através de gotículas, embora tenha sido encontrado também nas fezes e no sangue, admitindo-se assim, outros meios de potencial transmissão.  A sintomatologia associada à infeção por SARS-CoV -2 inclui a presença de febre, mialgia ou fadiga, tosse produtiva e/ou tosse não produtiva dispneia, fadiga ou mialgias na maioria dos casos. Existem ainda relatados de sintomas como a cefaleia, dor de garganta, hemoptises e sintomas gastrointestinais como a diarreia, náusea e dor abdominal, mas com menor incidência.AISI/HCI2020-06-30info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionInvited articleArtigo de convidadoapplication/pdfapplication/pdfhttps://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/100910.21876/rcshci.v10i3.1009Revista Ciências em Saúde; v. 10 n. 3 (2020): Julho a Setembro de 2020; 3-4Health Sciences Journal; Vol 10 No 3 (2020): July to September 2020; 3-42236-378510.21876/rcshci.v10i3reponame:Revista Ciências em Saúdeinstname:Hospital de Clínicas de Itajubáinstacron:HCIporenghttps://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1009/547https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1009/550Copyright (c) 2020 REVISTA CIÊNCIAS EM SAÚDEhttps://creativecommons.org/licenses/by-nc-sa/4.0info:eu-repo/semantics/openAccessSouza, Luís Manuel Mota deMarques, Maria do Céu Mendes Pinto2020-12-03T13:40:30Zoai:ojs.portalrcs.hcitajuba.org.br:article/1009Revistahttps://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zeroPUBhttps://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/oaircs@hcitajuba.org.br||rcsfmit@medicinaitajuba.com.br2236-37852236-3785opendoar:2020-12-03T13:40:30Revista Ciências em Saúde - Hospital de Clínicas de Itajubáfalse
dc.title.none.fl_str_mv Simulation training as a response to the demand of critical patients COVID19: safety and quality of care
Treinamento por simulação como resposta à demanda dos pacientes críticos COVID19: segurança e qualidade na assistência
title Simulation training as a response to the demand of critical patients COVID19: safety and quality of care
spellingShingle Simulation training as a response to the demand of critical patients COVID19: safety and quality of care
Souza, Luís Manuel Mota de
COVID-19
pandemic
COVID-19
pandemia
title_short Simulation training as a response to the demand of critical patients COVID19: safety and quality of care
title_full Simulation training as a response to the demand of critical patients COVID19: safety and quality of care
title_fullStr Simulation training as a response to the demand of critical patients COVID19: safety and quality of care
title_full_unstemmed Simulation training as a response to the demand of critical patients COVID19: safety and quality of care
title_sort Simulation training as a response to the demand of critical patients COVID19: safety and quality of care
author Souza, Luís Manuel Mota de
author_facet Souza, Luís Manuel Mota de
Marques, Maria do Céu Mendes Pinto
author_role author
author2 Marques, Maria do Céu Mendes Pinto
author2_role author
dc.contributor.author.fl_str_mv Souza, Luís Manuel Mota de
Marques, Maria do Céu Mendes Pinto
dc.subject.por.fl_str_mv COVID-19
pandemic
COVID-19
pandemia
topic COVID-19
pandemic
COVID-19
pandemia
description Coronavirus Disease (COVID-19), also known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first described in December 2019 in Wuhan, China. It has spread across all continents and was declared by the World Health Organization (WHO), on March 11, 2020, as a global pandemic. On June 24, 2020, 9,129,146 cases and 473,797 deaths from SARS-CoV-2 / COVID 19 were reported by the WHO. The virus is transmitted through droplets, although it has also been found in feces and blood, thus allowing other means of potential transmission. The symptoms associated with SARS-CoV -2 infection include fever, myalgia or fatigue, productive cough or non-productive cough dyspnoea, fatigue, or myalgia in most cases. There are also reports of symptoms such as headache, sore throat, hemoptysis and gastrointestinal symptoms such as diarrhea, nausea and abdominal pain, but with less incidence.  
publishDate 2020
dc.date.none.fl_str_mv 2020-06-30
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Invited article
Artigo de convidado
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1009
10.21876/rcshci.v10i3.1009
url https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1009
identifier_str_mv 10.21876/rcshci.v10i3.1009
dc.language.iso.fl_str_mv por
eng
language por
eng
dc.relation.none.fl_str_mv https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1009/547
https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1009/550
dc.rights.driver.fl_str_mv Copyright (c) 2020 REVISTA CIÊNCIAS EM SAÚDE
https://creativecommons.org/licenses/by-nc-sa/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2020 REVISTA CIÊNCIAS EM SAÚDE
https://creativecommons.org/licenses/by-nc-sa/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv AISI/HCI
publisher.none.fl_str_mv AISI/HCI
dc.source.none.fl_str_mv Revista Ciências em Saúde; v. 10 n. 3 (2020): Julho a Setembro de 2020; 3-4
Health Sciences Journal; Vol 10 No 3 (2020): July to September 2020; 3-4
2236-3785
10.21876/rcshci.v10i3
reponame:Revista Ciências em Saúde
instname:Hospital de Clínicas de Itajubá
instacron:HCI
instname_str Hospital de Clínicas de Itajubá
instacron_str HCI
institution HCI
reponame_str Revista Ciências em Saúde
collection Revista Ciências em Saúde
repository.name.fl_str_mv Revista Ciências em Saúde - Hospital de Clínicas de Itajubá
repository.mail.fl_str_mv rcs@hcitajuba.org.br||rcsfmit@medicinaitajuba.com.br
_version_ 1797068962807152640